Practice Areas
Bar Admissions
- District of Columbia
- Washington, D.C.
-
1111 Pennsylvania Ave., NW
Washington, DC 20004-2541
Phone: 202.739.5209
Fax: 202.739.3001
75 Publications Found
| Date | Title | Publication |
| 12/06/07 |
Assessing and Reducing Risks Associated with Medical Information/Product Information Communications, presented at ACI's 6th Managing Legal Risks and Avoiding Conflicts of Interest in Medical Affairs Conference, Philadelphia |
Speech |
| 06/19/07 |
Proactive Steps Every Provider Should Take to Avoid Government Scrutiny, presented at ACI's Preparing for Government Healthcare Fraud Enforcement Conference, Washington, D.C. |
Speech |
| 06/18/07 |
New Risks, New Plan: Drug Safety Concerns Show Need for Sophisticated Risk Management, Legal Times, Vol. 30, No. 25
View Article
|
Article |
| 05/17/07 |
Compliant Models for Medical Device Grants, presented at CBI's Premier West Coast Conference on Bio/Pharmaceutical and Medical Device Grants, San Francisco |
Speech |
| 05/17/07 |
Regulatory and Corporate Considerations in Life Sciences Industry Investments, presented at a Morgan Lewis Seminar, Palo Alto |
Speech |
| 04/17/07 |
The AdvaMed Code of Ethics, presented at the AdvaMed MTLI Conference: The Regulation of Advertising, Promotion, and Sales of Medical Devices, Washington, D.C. |
Speech |
| 2007 |
Keys to Successful Interactions with Governing Bodies, Inside the Minds: Food and Drug Law Settlements and Negotiations
View Article
|
Article |
| 2006/07 |
Overview of Healthcare Fraud Investigations in the U.S., PLC Cross-border Life Sciences Handbook 2006/07
View Chapter
|
Chapter |
| 07/18/06 |
Crossing Paths with the FDA—Regulatory Influence on the Defense of Drug and Device Products, presented at the Defense Research Institute Teleconference |
Speech |
| 03/29/06 |
Generic Drug Issues: Authorized Generics, presented at the Temple University School of Pharmacy FDA/Industry Conference |
Speech |
| 03/07/06 |
The New Medicare Act and Its Effects on Life Sciences Companies, presented to the New Jersey Technology Council Life Sciences Industry Network |
Speech |
| 2005/06 |
Overview of Healthcare Fraud Investigations in the U.S., PLC Cross-border Life Sciences Handbook |
Chapter |
| July/August 2004 |
New Medicare Act Provides New Competitive Landscape for the Pharmaceutical Industry, FDLI Update, Vol. 36
View Article
|
Article |
| 02/28/03 |
FDA Must Clarify Drug Makers' Ability to Publicly Defend Products, Litigation Legal Foundation Legal Update, Vol. 13, No. 7
View Article
|
Article |
| 11/04/02 |
Navigating a Pathway to FDA Approval
View Presentation
|
Speech |
| 09/06/02 |
FTC, Not FDA, Should Regulate Online Food Information, Legal Backgrounder, Vol. 17, No. 38 |
Article |
| 08/01/02 |
FDA Challenges to Pharmaceutical Company Control of Product Lifecycle Management, FDLI Update
View Article
|
Article |
| August 2002 |
Market Exclusivity: New Legal Developments and Pharmaceutical Marketing Implications, Regulatory Affairs Focus |
Article |
| 04/23/02 |
HIPAA: What Medical Device Firms Should Be Doing Now
View Presentation
|
Speech |
| 04/01/02 |
Be Wary of HP Lawsuits: Emerging Firms, presented to AvaMed, Washington, D.C.
View Presentation
|
Speech |
| March 2002 |
Pharmaceutical Pricing: System Changes And Global Effects, Metropolitan Corporate Counsel |
Article |
| 02/01/02 |
Corporate Response to CPSC Challenge - Legal, Technical, and Public Relations Issues, presented at the ICPHSO 9th Annual Meeting of the ABA Product Safety Seminar, Washington, D.C.
View Presentation
|
Speech |
| 2003 |
Consumer Products Regulation (Chapter 13), Developments in Administrative Law and Regulatory Practice 2002-2003 (ABA Section on Administrative Law) |
Chapter |
| August 2001 |
U.S. Pharmaceutical Pricing: System Changes and Global Effects, Life Sciences Industry Report |
Article |
| January 2001 |
It's Worse Than You Think: US Regulatory Changes Require Pharmaceutical Company Attention, International Financial Law Review: Competition & Antitrust (Special IFLR Supplement) |
Article |